Maier Paul V
- SEC CIK
- 0001182615
In the past year, 2 open-market sale filings worth $2.96M and no purchases.
Current role at each company
- ISCO International Stem Cell CORPDirectoras of Sep 17, 2026
- ETON Eton Pharmaceuticals, Inc.Directoras of Aug 31, 2026
- AMAM Ambrx Biopharma, Inc.Directoras of Mar 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.96M
- 2 filings
- Net
- −$2.96M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Maier Paul V as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ISCO International Stem Cell CORP
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:12 PM ET | Sep 11 | 4 days | Maier Paul VDirector | SSale | −32.8K | $0.32 | −$10.5K | −100.0%0 after |
ETON Eton Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)4:06 PM ET | Aug 28 | 3 days | Maier Paul VDirector | SSale | −50.0K | $59.07 | −$2.95M | −45.6%59.7K after | Amended3 lots |